| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.67▼ | 4.67▼ | 4.67▼ | 4.74▼ | 5.28▼ |
| MA10 | 4.76▼ | 4.77▼ | 4.77▼ | 5.13▼ | 5.18▼ |
| MA20 | 4.79▼ | 4.78▼ | 4.74▼ | 5.34▼ | 6.73▼ |
| MA50 | 4.67▼ | 4.87▼ | 5.12▼ | 5.29▼ | 8.05▼ |
| MA100 | 4.61▼ | 5.23▼ | 5.37▼ | 6.90▼ | 9.54▼ |
| MA200 | 5.14▼ | 5.47▼ | 5.28▼ | 8.32▼ | 15.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.053▼ | -0.024▼ | 0.002▲ | -0.085▼ | -0.184▼ |
| RSI | 38.680▼ | 42.464▼ | 41.525▼ | 41.155▼ | 41.117▼ |
| STOCH | 30.483 | 39.332 | 41.211 | 45.757 | 31.589 |
| WILL %R | -96.591▼ | -96.591▼ | -96.591▼ | -53.910 | -84.090▼ |
| CCI | -155.490▼ | -138.442▼ | -138.154▼ | -79.455 | -67.994 |
|
Wednesday, June 24, 2026 07:18 PM
The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans.
|
|
Wednesday, June 24, 2026 04:30 PM
Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics.
|
|
Wednesday, May 20, 2026 01:35 AM
Passage Bio Inc (NASDAQ:PASG) is one of the best gene therapy stocks to buy in 2026. While the stock is down around 50% year-to-date, analysts see it surging 125% over the next 12 months. On April 20, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/26 | 4.64 | 4.73 | 4.4501 | 4.68 | 44,640 |
| 01/07/26 | 4.92 | 4.92 | 4.42 | 4.58 | 57,703 |
| 30/06/26 | 4.90 | 4.99 | 4.81 | 4.88 | 89,291 |
| 29/06/26 | 4.58 | 5.00 | 4.58 | 4.85 | 102,781 |
| 26/06/26 | 4.30 | 5.00 | 4.1901 | 4.70 | 269,473 |
| 25/06/26 | 4.99 | 4.99 | 3.295 | 4.33 | 770,048 |
| 24/06/26 | 6.27 | 6.30 | 5.78 | 5.88 | 50,302 |
| 23/06/26 | 5.68 | 6.23 | 5.544 | 6.12 | 96,566 |
| 22/06/26 | 5.60 | 5.85 | 5.60 | 5.72 | 37,783 |
| 18/06/26 | 5.34 | 5.65 | 5.27 | 5.59 | 68,229 |
|
|
||||
|
|
||||
|
|